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Case report

Moyamoya disease: A case report
Latha T, Girish Menon R*
Email: girish.menon@manipal.edu

Abstract
Moyamoya disease is a rare cause for hemorrhagic stroke in adults. The authors present the case of a 39 years old
man, who presented with features of intracerebral hemorrhage secondary to Moyamoya disease. He was a known case
of diabetes mellitus, hypertension and had a past history of ischemic stroke. Left temporoparietal craniotomy and
encephaloduroarteriomyosynangiosis (EDAM’S) was performed for the same. Patient got discharged on fifth postoperative day without any complication. The etiopathogeneses, clinical features, and management are discussed in this
paper.
Key words: Moyamoya disease, encephalodurangiomyongiosis (EDAM’S), digital subtraction angiography (DSA),
stroke, headache

Introduction
Moyamoya disease is a chronic cerebrovascular disorder
characterized by an initial obliterative vaso-occlusive
phase followed by a vaso-proliferative phase. The
progressive occlusion of supraclinoid intracranial
Internal Carotid Artery (ICA) and its proximal branches,
mainly middle cerebral artery and anterior cerebral
artery is seen in the initial phase. As a compensatory
phenomenon and collaterals develop from the basal
perforators (Duan et al., 2012)These collateral vessels
appear as “smoky puffs” in carotid angiography.
Though it was first described by Takeuchi and Shimizu
in 1957 (Takeuchi & Shimizu, 1957) and later in 1969,
Suzuki and Takaku called it as Moyamoya (means puff
of smoke in Japanese) (Suzuki & Takaku, 1969).
Case report
A 39 years old male patient presented to neurosurgery
department with the history of severe headache for one
week. The headache was holocranial in nature. There
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was a history of associated vomiting and giddiness with
blurring of vision. There was no history of any new
onset of limb weakness, transient ischemic attack (TIA)
or sudden loss of consciousness in last two years.
Patient had the past history of right Cerebrovascular
Accident (CVA) four years back. He also had bilateral
pyelonephritis with papillary necrosis with Enterococcal
Sepsis and Candidemia. Bilateral double J (D-J) stenting
was done four years back. Patient is a known case of
Type-2 diabetes mellitus and hypertensive for four years
and on regular treatment.
Patient was conscious, alert, and oriented. His
Glasgow Coma Scale (GCS) was 15 (E4 V5 M6). His
vital signs were stable; heart rate was 80/min, blood
pressure was 140/100 mmHg, respiratory rate was 20
breaths/min, and temperature was 98.60 F. Right side
pupil was measuring two mm and was reacting to
light. He had intraocular lens in the left side. Higher
mental function was normal and had mild slurring of
speech. Fundoscopic examination of the eye revealed
papilloedema. Muscle tone was normal with power 4/5
in right upper and lower limb and pronator drift was
positive. However, there was no sensory deficits and
deep tendon reflex was 2+ with no cerebellar signs.
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Hematological parameters (renal function test, blood glucose levels, serum electrolytes and blood counts) were
within the normal limit. CT brain was suggestive of intraventricular hemorrhage in bilateral lateral ventricles and
third ventricle with dilatation of body and temporal horn of left lateral ventricle (Figure 1).

Figure 1: CT scan showing presence of bleed in the lateral ventricle – body, temporal horn and atria

Digital subtraction angiography was suggestive of stenosis of anterior cerebral artery and middle cerebral artery
(Figures 2, 3 and 4).

Figure 2: A: Right ICA AP injection showing stenosis of supraclinoid ICA & Moyamoya vessels. B: Right ECA injection showing collaterals
from ECA
78
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ICA: Internal carotid artery, ECA: External carotid
artery

These basal collaterals mimic a “puff of smoke” from
which the name Moyamoya was derived (Gosalakkal,
2002).
Moyamoya disease was initially thought to be only found
among the Japanese and the oriental population. But of
later, several reports from India and western countries
are being published [(Duan et al., 2012) (Chiu, Shedden,
Bratina, & Grotta, 1998); (Yilmaz, Pritz, Bruno, LopezYunez, & Biller, 2001); and (Uchino, Johnston, Becker,
& Tirschwell, 2005)]. Japanese population has a higher
incidence of pediatric Moyamoya whereas the western
literature cites a higher incidence of adult Moyamoya.

Figure 3: Left ICA injection showing a) occlusion of supraclinoid
ICA and b) blush of collaterals from the basal perforators

Figure 4: Vertebral injection showing diffuse blush of perforators

Left temporoparietal craniotomy and EDAM’S was
performed. Post-operative period was uneventful.
Discussion
Moyamoya disease is a rare cause for stroke characterized
by progressive stenosis of internal carotid artery and
formation of a collateral network of basal perforators.

Moyamoya patients present either with ischemic stroke
or with intracerebral bleed. The ischemic stroke is more
common among children. The bleeding is due to rupture
of delicate collaterals or rupture of small aneurysms
seen in these collaterals. Usually, adults are vulnerable
for bleeds. The clinical manifestations are headache,
transient ischemic attack, infarct, hemorrhage, seizure,
syncope [(Duan et al., 2012) and (Han et al., 2016)].
However, some of the patients remain asymptomatic
(Duan et al., 2012) Among all the symptoms, ischemia
is noted to be the most frequently occurring symptoms
(Duan et al., 2012) and is the most common form of
presentation among children.
Moyamoya usually affects bilateral carotid arteries
than unilateral (Duan et al., 2012) It is still unclear if
all patients with unilateral MMD progress to bilateral
MMD. The etiopathology of the disease is unclear.
MMD is often associated with neurofibromatosis,
Down syndrome, Turner syndrome, sickle cell anemia,
Wilms tumour, meningitis, and cranial irradiation.
Some authors prefer to call such secondary cases as
Moyamoya syndrome and the others as Moyamoya
disease. The identified risk factors are hypertension,
diabetes mellitus, dyslipidemia, hyperhomocysteinemia
and carotid plaques (Han et al., 2016), female, family
history (Duan et al., 2012) smoking, ischemic heart
disease and hypertension (Jin et al., 2016). The
pathogenesis of Moyamoya is not well established.
One hypothesis states that the disease is associated with
the growth of fibroblast which is responsible for the
angiogenesis (Malek, Connors, Robertson, Folkman, &
Scott, 1997). Another postulate is role of prostaglandin
in promoting the thickening of cerebral blood vessels
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leading to partial or complete occlusion (Yamamoto,
M., Fukai, Matsushima, & Yamamoto, 1999).
The vascular changes are evident in imaging studies such
as cerebral angiogram and High-Resolution Magnetic
Resonance Imaging (HRMRI) showing intimal fibrous
thickening, widening of the internal elastic lamina and
thinning of the media and presence of collateral around
the circle of Willis and small vessels of conglomerated
networks in the pia mater (Gosalakkal, 2016). HRMRI
is useful in diagnosing Moyamoya disease. HRMRI not
only helps in diagnosis of Moyamoya, it also found
to be useful in detecting atherosclerotic plaques along
with Moyamoya progression [(Han et al., 2016) and (Yu
et al., 2016)]. Still, DSA remains as the gold standard in
diagnosing the disease. Occlusion levels are categorized
in terms of Suzuki staging (Table 1).
Table 1:
Suzuki Stages of Moyamoya Disease (Takahashi, Fujiwara, &
Suzuki, 1986)
Suzuki Stage

Angiographic Finding

I

Narrowing of carotid arteries

II

Initial appearance of Moyamoya vessels

III

Intensification of Moyamoya vessels

IV

Minimization of Moyamoya vessels

V

Reduction of Moyamoya vessels

VI

Disappearance of Moyamoya vessels

The effective treatment of Moyamoya is not yet proven.
The surgical procedures performed to treat the disease
among adult patients are direct bypass, indirect bypass
and combined bypass. In direct bypass, a superficial
temporal artery (STA) is anastomosed to middle cerebral
artery. Direct method of revascularization is effective
in patients with ischemic strokes. Indirect procedures
which augment the blood supply to the deprived areas
of cerebral tissue are Encephaloduroarteriosynangiosis
(EDAS), Encephalomyosynangiosis (EMS) or
Omental cerebral transposition. However, a recent
meta-analysis shows that direct or combined bypass
gives better results in terms of revascularization (Kim
et al., 2016). Few patients would develop peri-operative
complications such as symptomatic stroke, permanent
neurologic deficits, and rarely death (Kim et al., 2016).
Nevertheless, there is a high risk of stroke among nonsurgically treated adult patients (Jin et al., 2016), (Lee
et al., 2012) and surgery is the current standard of care
for patients with proven Moyamoya disease.
80

The disease progresses without treatment. The patients
with ischemic stroke remain with neurological deficits.
Surgery helps to arrest the advancement of disease.
Prognosis following surgery is good and majority may
not have disabilities (Duan et al., 2012)
Our patient presented with features suggestive of
hemorrhagic Moyamoya disease. The bleed in such
patients is attributed to rupture of the fragile collateral
or rupture from a small aneurysm in these collaterals.
Role of surgery in Moyamoya disease is debatable.
However, since our patient had a relapse, we decided to
perform a revascularization procedure. He underwent
indirect anastomosis (EDAMS) and uneventful
recovery and is doing well at one year follow up.
Conclusion
Moyamoya is a rare form of stroke which can be
treated surgically. Cerebral revascularization helps
in preventing further progression of the disease and
thereby improving the quality of life. Proper awareness
and prompt diagnosis helps in early detection and
management.
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